From the Department of Biochemistry and Molecular Biology and.
From the Department of Biochemistry and Molecular Biology and; the Stanley S. Scott Cancer Center, Louisiana State University School of Medicine, New Orleans, Louisiana 70112.
J Biol Chem. 2018 Nov 23;293(47):18192-18206. doi: 10.1074/jbc.RA118.003716. Epub 2018 Oct 4.
The NEDD4-2 (neural precursor cell-expressed developmentally down-regulated 4-2) HECT ligase catalyzes polyubiquitin chain assembly by an ordered two-step mechanism requiring two functionally distinct E2∼ubiquitin-binding sites, analogous to the trimeric E6AP/UBE3A HECT ligase. This conserved catalytic mechanism suggests that NEDD4-2, and presumably all HECT ligases, requires oligomerization to catalyze polyubiquitin chain assembly. To explore this hypothesis, we examined the catalytic mechanism of NEDD4-2 through the use of biochemically defined kinetic assays examining rates of I-labeled polyubiquitin chain assembly and biophysical techniques. The results from gel filtration chromatography and dynamic light-scattering analyses demonstrate for the first time that active NEDD4-2 is a trimer. Homology modeling to E6AP revealed that the predicted intersubunit interface has an absolutely conserved Phe-823, substitution of which destabilized the trimer and resulted in a ≥10-fold decrease in for polyubiquitin chain assembly. The small-molecule Phe-823 mimic, -acetylphenylalanyl-amide, acted as a noncompetitive inhibitor ( = 8 ± 1.2 mm) of polyubiquitin chain elongation by destabilizing the active trimer, suggesting a mechanism for therapeutically targeting HECT ligases. Additional kinetic experiments indicated that monomeric NEDD4-2 catalyzes only HECT∼ubiquitin thioester formation and monoubiquitination, whereas polyubiquitin chain assembly requires NEDD4-2 oligomerization. These results provide evidence that the previously identified sites 1 and 2 of NEDD4-2 function in to support chain elongation, explicating the requirement for oligomerization. Finally, we identified a conserved catalytic ensemble comprising Glu-646 and Arg-604 that supports HECT-ubiquitin thioester exchange and isopeptide bond formation at the active-site Cys-922 of NEDD4-2.
NEDD4-2(神经前体细胞表达的发育下调 4-2)HECT 连接酶通过需要两个功能不同的 E2∼泛素结合位点的有序两步机制催化多泛素链组装,类似于三聚体 E6AP/UBE3A HECT 连接酶。这种保守的催化机制表明,NEDD4-2,以及推测的所有 HECT 连接酶,都需要寡聚化来催化多泛素链组装。为了探索这一假设,我们通过使用生化定义的动力学测定来检查 NEDD4-2 的催化机制,该测定检查了 I 标记的多泛素链组装的速率和生物物理技术。凝胶过滤色谱和动态光散射分析的结果首次表明,活性 NEDD4-2 是三聚体。与 E6AP 的同源建模揭示了预测的亚基间界面具有绝对保守的 Phe-823,取代它会使三聚体不稳定,并导致多泛素链组装的 降低≥10 倍。小分子 Phe-823 模拟物,-乙酰苯丙氨酸酰胺,作为非竞争性抑制剂(=8±1.2mm),通过使活性三聚体不稳定来抑制多泛素链延伸,这表明了针对 HECT 连接酶的治疗靶标的机制。额外的动力学实验表明,单体 NEDD4-2 仅催化 HECT∼泛素硫酯形成和单泛素化,而多泛素链组装需要 NEDD4-2 寡聚化。这些结果提供了证据表明,先前鉴定的 NEDD4-2 的位点 1 和 2 起作用以支持链延伸,阐明了寡聚化的要求。最后,我们确定了一个保守的催化组,包括 Glu-646 和 Arg-604,该组支持 HECT-泛素硫酯交换和 NEDD4-2 活性位点 Cys-922 的异肽键形成。